Exelixis
EXEL
#1622
Rank
NZ$22.78 B
Marketcap
NZ$90.65
Share price
0.76%
Change (1 day)
29.74%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company